Allenex AB Release: Year-End Report 2011

23 Feb 2012

·www.biospace.com

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): For the fourth quarter, October - December · Net sales for the quarter were SEK 27.5 million (20.0), an increase of 37.5 percent year on year. The quarter’s results included full sales figures from Olerup GmbH, which was consolidated into the group as of June 1, 2011.

Organizations

CareDx International ABOlerup GmbH

Indications

Targets

Drugs

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.